Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cidara Thera (NQ: CDTX )

2.430 USD -0.040 (-1.62%)
Official Closing Price Updated: 7:13 PM EST, Feb 24, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 742,300
Open 2.500
Bid (Size) 2.400 (1)
Ask (Size) 2.430 (2)
Prev. Close 2.470
Today's Range 2.380 - 2.540
52wk Range 1.300 - 4.450
Shares Outstanding 27,678,169
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
UTILITY Therapeutics Joins Antimicrobials Working Group
The Antimicrobials Working Group (AWG) announced today the addition of UTILITY therapeutics Ltd. (UTILITY) to its coalition of companies with the mission to combat drug resistant infections and spur... 
From PR Newswire
Cidara Therapeutics Announces New Data for Rezafungin at the 21st ICHS Symposium
New analyses from completed Phase 2 STRIVE trial support once-weekly, long-acting rezafungin for the treatment of candidemia and invasive candidiasis in high-risk patient populations 
From GlobeNewswire News Releases

Performance

YTD
+17.96%
+17.96%
1 Month
-5.81%
-5.81%
3 Month
+5.65%
+5.65%
6 Month
-28.74%
-28.74%
1 Year
-15.62%
-15.62%

More News

Read More
Cidara Therapeutics to Present New Data for Rezafungin and Influenza AVCs at the 21st ICHS Symposium
From GlobeNewswire News Releases
Cidara Therapeutics Announces Key Additions to its Board of Directors
From GlobeNewswire News Releases
Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Cidara Therapeutics Appoints Biotechnology Industry Veteran Christopher Kurtz As Executive Vice President of Technical Operations
From GlobeNewswire News Releases
Cidara Therapeutics to Present Preclinical Data for Influenza AVCs at the 7th ESWI Influenza Conference
From GlobeNewswire News Releases
Cidara Therapeutics to Present New Clinical Data for Rezafungin at ESICM LIVES 2020
From GlobeNewswire News Releases
Cidara Therapeutics Named a San Diego Metro Area Top Workplace for the Fourth Consecutive Year
From GlobeNewswire News Releases
Cidara Therapeutics to Participate in Two Upcoming Investor Conferences
From GlobeNewswire News Releases
Cidara Provides Corporate Update and Reports Third Quarter 2020 Financial Results
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.